My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2004-122
CBCC
>
Official Documents
>
2000's
>
2004
>
2004-122
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/1/2016 10:56:20 AM
Creation date
9/30/2015 7:35:51 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Application
Approved Date
06/01/2004
Control Number
2004-122
Agenda Item Number
7.S.
Entity Name
Florida Department of Law Enforcement
Subject
Edward Byrne Formula Grant Program Funds
Multi-Agency Drug Enforcement Unit (MACE)
Archived Roll/Disk#
3210
Supplemental fields
SmeadsoftID
3809
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
78
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Application for Funding Assistance <br /> Florida Department of Law Enforcement <br /> Edward Byrne Memorial State and Local Law Enforcement Assistance Formula Grant Pro ram <br /> the court's monitoring of participant compliance . It is a main objective of the program . <br /> It gives the participant immediate information about his or her own progress , making <br /> the participant active and involved in the treatment process rather than a passive <br /> recipient of services . <br /> Performance Objectives : <br /> The Indian River County Drug Testing Program proposes to provide IRC juveniles <br /> frequent drug testing according to the following standards . <br /> 1 . AOD testing policies and procedures are based on established and tested <br /> guidelines . <br /> 2 . Testing may be administered randomly or at scheduled intervals , but occurs no <br /> less than once a week during the first several months of an individual 's <br /> enrollment . Frequency thereafter will vary depending on participant progress . <br /> 3 . The scope of testing is sufficiently broad to detect the participant' s primary drug <br /> of choice as well as other potential drugs of abuse , including alcohol . <br /> 4 . The drug -testing procedure will be certain . Elements contributing to the reliability <br /> and validity of a urinalysis testing process include , but are not limited to : <br /> • Direct observation of urine sample collection <br /> • Verification temperature and measurement of adulterants ie : creatinine levels , <br /> specific gravity , nitrite levels , PH , oxidants and chromate to determine the <br /> extent of water loading and other adulteration techniques <br /> • Specific , detailed , written procedures regarding all aspects of urine sample <br /> collection , sample analysis , and result reporting ; <br /> • A documented chain of custody for each sample collected <br /> • Quality control and quality assurance procedures for ensuring the integrity of <br /> the process <br /> • Procedures for verifying accuracy when drug test results are contested . <br /> 5 . Ideally , test results are available and communicated to the court and the <br /> participant within one day. The court functions best when it can to respond <br /> immediately to noncompliance ; the time between sample collection and availability <br /> of results should be short . <br /> 6 . The court is immediately notified when a participant has tested positive , has failed <br /> to submit to AOD testing , has submitted the sample of another, or has adulterated <br /> a sample . <br /> 7 . The coordinated strategy for responding to noncompliance includes prompt <br /> responses to positive tests , missed tests , and fraudulent tests . <br /> FDLE Byrne Formula Grant Application Package Grant Application <br /> Section 11 - Page 6 <br /> Rule 11 D-9 .006 OCJG — 005 (rev. April 2004) <br />
The URL can be used to link to this page
Your browser does not support the video tag.